Media stories about RTI Surgical (NASDAQ:RTIX) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. RTI Surgical earned a news sentiment score of 0.00 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 46.3893961602737 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
These are some of the media headlines that may have effected Accern Sentiment’s rankings:
- Zacks: Brokerages Anticipate RTI Surgical Inc (RTIX) Will Announce Quarterly Sales of $70.16 Million (americanbankingnews.com)
- Reviewing RTI Surgical (RTIX) & The Competition (americanbankingnews.com)
- RTI Surgical (RTIX) Downgraded by BidaskClub to “Sell” (americanbankingnews.com)
- Analyzing RTI Surgical (RTIX) and Its Rivals (americanbankingnews.com)
- RTI Surgical (RTIX) & Its Rivals Critical Survey (americanbankingnews.com)
RTI Surgical (RTIX) traded up $0.10 during trading hours on Thursday, hitting $4.30. 401,800 shares of the stock were exchanged, compared to its average volume of 186,457. The firm has a market capitalization of $255.50, a price-to-earnings ratio of 105.00, a P/E/G ratio of 5.60 and a beta of 1.76. RTI Surgical has a 1 year low of $3.01 and a 1 year high of $6.00. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.34 and a quick ratio of 1.21.
A number of research analysts have issued reports on the stock. Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, October 13th. BidaskClub cut shares of RTI Surgical from a “hold” rating to a “sell” rating in a report on Tuesday, December 5th.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.